GB941634A - Improvements in or relating to steroids and the manufacture thereof - Google Patents
Improvements in or relating to steroids and the manufacture thereofInfo
- Publication number
- GB941634A GB941634A GB3701461A GB3701461A GB941634A GB 941634 A GB941634 A GB 941634A GB 3701461 A GB3701461 A GB 3701461A GB 3701461 A GB3701461 A GB 3701461A GB 941634 A GB941634 A GB 941634A
- Authority
- GB
- United Kingdom
- Prior art keywords
- methyl
- compound
- hydrogen
- hydroxy
- treated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
The invention comprises 7-methyl-testosterones having the formulae: <FORM:0941634/C2/1> <FORM:0941634/C2/2> <FORM:0941634/C2/3> <FORM:0941634/C2/4> wherein R1 is hydrogen, a - or b -hydroxy, a -acyloxy, or keto, R is b -hydroxy, a -methyl-b -hydroxy, a -methyl-b -acyloxy or b -acyloxy, X is hydrogen, fluorine, chlorine, bromine or iodine and C is >C=O or <FORM:0941634/C2/5> wherein R111 is hydrogen or a lower aliphatic hydrocarbon radical and Y is hydrogen or acyl wherein the acyl radical is that of a hydrocarbon carboxylic acid containing 1-12 carbon atoms, a 7a -methyl 17a -alkynyl testosterone having the formula <FORM:0941634/C2/6> wherein R is hydrogen, methyl or ethyl, and R1 is hydrogen or acyl and acyl is as defined above, 7a -methyl-17a -ethyltestosterone and 17-acylates thereof, a compound having the formula: <FORM:0941634/C2/7> wherein Y is as defined above and W is methyl or ethyl, pharmaceutical compositions thereof and processes for the preparation thereof. The 1-dehydro compounds obtained by treating 7-methyltestosterone with a 1-dehydrogenating microorganisum, e.g. Septomyxa, may be dehydrated at 9 and 11 positions to form a D 9(11) -compound, which may be treated with hypohalous acid to form a D 1-7-methyl-9a -halo-11b -hydroxytestosterone, which may be treated with a weak base to form a 9b , 11b -epoxy compound, which may be treated with hydrofluoric acid to form a D 1-7-methyl-9a -fluoro-11b -hydroxytestosterone, which may be oxidised with chromic acid to form the corresponding 11-keto compound. A 17-ester group when present may by hydrolysed to form a free 17-hydroxy compound. 7a -Methyl-19-nortestosterones obtained by treating a 6-dehydro-19-nor-testosterone with a methyl Grignard reagent in the presence of cuprous chloride, may be hydroxylated at 11-position by treatment with a suitable micro-organism and the 11b -hydroxy compound so obtained oxidised with chromic acid at 11 position to obtain an 11-keto compound or at both positions 11 and 17 to obtain an 11,17-diketo compound. The 7-methyl-3,17-dione compound in the form of its 3-enamine may be treated with a Grignard compound, an alkyl or alkenyl lithium compound, or alkali metal alkyne derivative to obtain the corresponding 17-alkylated-7-methyl-19-nortestosterone, the 17-hydroxy group of which may be acylated. Again hydroxylation followed by oxidation at 11-position may be effected if desired. The 7a -methyl-19-nortestosterones may be dehydrogenated, e.g. with Septomyxa affinis, to yield the corresponding 7a -methylestrones and 7a -methylestradiols. 7a -Methyl-17a -alkynyl-testosterones are obtained by treating the 3-enamine of 7a -methylandrostene-3,17-dione with an alkali metal derivative of an alkyne and hydrolysing the 7a -methyl-17a -alkynyltestosterone 3-enamine so obtained. Said pharmaceutical compositions, having anabolic, androgenic, anti-estrogenic, gonado-tropic inhibiting, progestational, growth promoting, antifertility and central nervous depressant activity, are employed orally or parenterally as tablets, powders, capsules or pills, solutions, emulsions, suspensions, syrups, or elixirs. Specifications 724,094, 833,183, 853,981 and 863,661 are referred to.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6955760A | 1960-11-16 | 1960-11-16 | |
US11462561A | 1961-06-05 | 1961-06-05 | |
US114621A US3341557A (en) | 1961-06-05 | 1961-06-05 | 7-methyltestosterones |
Publications (1)
Publication Number | Publication Date |
---|---|
GB941634A true GB941634A (en) | 1963-11-13 |
Family
ID=27371563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB3701461A Expired GB941634A (en) | 1960-11-16 | 1961-10-16 | Improvements in or relating to steroids and the manufacture thereof |
Country Status (3)
Country | Link |
---|---|
BE (1) | BE610385A (en) |
CH (2) | CH432508A (en) |
GB (1) | GB941634A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2054527A1 (en) * | 1969-07-28 | 1971-04-23 | Roussel Uclaf | |
EP0159739A1 (en) * | 1984-03-21 | 1985-10-30 | Akzo N.V. | Steroids for use as immunomodulators |
US8466136B2 (en) | 2005-10-12 | 2013-06-18 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
US9125816B2 (en) | 2000-08-30 | 2015-09-08 | Besins Healthcare Inc. | Pharmaceutical composition and method for treating hypogonadism |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3506651A (en) * | 1966-06-30 | 1970-04-14 | Shionogi Seiyaku Kk | Epoxysteroids |
-
1961
- 1961-10-16 GB GB3701461A patent/GB941634A/en not_active Expired
- 1961-11-03 CH CH1443765A patent/CH432508A/en unknown
- 1961-11-03 CH CH1276061A patent/CH401040A/en unknown
- 1961-11-16 BE BE610385A patent/BE610385A/en unknown
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2054527A1 (en) * | 1969-07-28 | 1971-04-23 | Roussel Uclaf | |
EP0159739A1 (en) * | 1984-03-21 | 1985-10-30 | Akzo N.V. | Steroids for use as immunomodulators |
US4701450A (en) * | 1984-03-21 | 1987-10-20 | Akzo N.V. | Steroids for use as immunomodulators |
US9132089B2 (en) | 2000-08-30 | 2015-09-15 | Besins Healthcare Inc. | Pharmaceutical composition and method for treating hypogonadism |
US9125816B2 (en) | 2000-08-30 | 2015-09-08 | Besins Healthcare Inc. | Pharmaceutical composition and method for treating hypogonadism |
US8486925B2 (en) | 2005-10-12 | 2013-07-16 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
US8466138B2 (en) | 2005-10-12 | 2013-06-18 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
US8729057B2 (en) | 2005-10-12 | 2014-05-20 | Unimed Pharmaeuticals, LLC | Testosterone gel and method of use |
US8741881B2 (en) | 2005-10-12 | 2014-06-03 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
US8754070B2 (en) | 2005-10-12 | 2014-06-17 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
US8759329B2 (en) | 2005-10-12 | 2014-06-24 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
US8466137B2 (en) | 2005-10-12 | 2013-06-18 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
US8466136B2 (en) | 2005-10-12 | 2013-06-18 | Unimed Pharmaceuticals, Llc | Testosterone gel and method of use |
Also Published As
Publication number | Publication date |
---|---|
CH401040A (en) | 1965-10-31 |
CH432508A (en) | 1967-03-31 |
BE610385A (en) | 1962-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3198792A (en) | 10alpha methyl, 9beta hormonal steroids | |
US3414592A (en) | 6, 7-halomethylene androstanes and estranes and processes for their preparation | |
US2793218A (en) | 9alpha-halo-11-keto-17-alkyltestosterones | |
GB941634A (en) | Improvements in or relating to steroids and the manufacture thereof | |
US3445489A (en) | 9beta,10alpha-steroids,intermediates therefor and pharmaceutical preparations containing these compounds as an active ingredient | |
US3246014A (en) | Optionally 6-methylated 17alpha-alkynyl-17beta-oxygenated-2-oxa-5alpha-androstan-3-ones, 19-nor compounds corresponding, and delta4 and delta5(10) derivatives thereof | |
US2946812A (en) | Synthesis of steroids | |
GB1146991A (en) | Improvements in or relating to novel steroids and the manufacture thereof | |
US3338957A (en) | A-norpregnene compounds and intermediates therefor | |
US2991295A (en) | 11beta-hydroxy-17alpha-alkyl estrogens and intermediates in the production thereof | |
Djerassi et al. | The synthesis of 8-isoprogesterone and 8-isotestosterone | |
US3356677A (en) | 1alpha, 2alpha-and 6alpha, 7alpha-dihalomethylene androstenes | |
US3270008A (en) | Novel process for 3-oxo-delta4, 6 steroids | |
US3194832A (en) | 18-nor-d-homo-steroids | |
US3278528A (en) | 5alpha-halo-4beta, 19-oxido steroids and process for production thereof | |
US3294819A (en) | Synthesis of steroids | |
US3412112A (en) | 3beta, 10alpha-17beta-triol-gon-4-enes and derivatives thereof | |
US3312720A (en) | 3-desoxy-19-nor-androstenes | |
US3154569A (en) | 19-nitrilosteroids and process for producing 19-norsteroids | |
US3054809A (en) | 1-cyano-androstanes | |
US3020294A (en) | Production of ring a aromatic steroids | |
US2927109A (en) | 3-deoxy-11, 17-oxygenated-androstanes | |
US3041359A (en) | 2, 2-dialkyl androgenic type hormones | |
US3221034A (en) | 3,3-difluoroandrostanes | |
US3435029A (en) | 16 - oxygenated - 20 - methyl - 21 - oic acids and 16 - oxygenated - 17alpha,20 - methylene-21-oic acids of the pregnane series and the 21-lower alkyl esters thereof |